Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real-time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio platform is used globally across a wide range of medical specialties and is revolutionizing the way physicians diagnose and treat patients — making a transformative change in medicine.
View Top Employees from Mauna Kea TechnologiesWebsite | http://www.maunakeatech.com |
Ticker | MKEA |
Revenue | $9 million |
Funding | $60.5 million |
Employees | 121 (100 on RocketReach) |
Founded | 2000 |
Phone | +33 1 48 24 03 45 |
Fax | +33 1 48 24 12 18 |
Technologies |
JavaScript,
HTML,
Twitter
+32 more
(view full list)
|
Industry | Medical Equipment Manufacturing, Vitamins, Supplements & Health Stores, Biotechnology, Medical Devices, Retail, Science and Engineering, Optical Biopsy, Medical, Endomicroscopy, Health Care, In Vivo Microscopy, Medical Device, Cancer Imaging |
Web Rank | 3 Million |
Keywords | Medical Imaging |
Competitors | Caliber Imaging & Diagnostics, Inc., DYSIS Medical, Nanotronics, Optiscan Imaging Ltd, Synoptics Ltd |
SIC | SIC Code 38 Companies, SIC Code 384 Companies |
NAICS | NAICS Code 33 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Mauna Kea Technologies employee's phone or email?
The Mauna Kea Technologies annual revenue was $9 million in 2024.
Francois LACOMBE is the Chief Innovation Officer of Mauna Kea Technologies.
100 people are employed at Mauna Kea Technologies.
The NAICS codes for Mauna Kea Technologies are [33, 54, 541].
The SIC codes for Mauna Kea Technologies are [38, 384].